Cargando…

Case report: Denosumab-associated acute heart failure in patients with cardiorenal insufficiency

Denosumab is a pivotal treatment for postmenopausal women with osteoporosis. Although its clinical use is generally well tolerated by patients, denosumab in patients with renal insufficiency may increase the risk of hypocalcemia. Thus, we have to consider the population of denosumab in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Yuexian, Ju, Sicong, Sun, Mengyu, Xiang, Shoukui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515392/
https://www.ncbi.nlm.nih.gov/pubmed/36187135
http://dx.doi.org/10.3389/fendo.2022.970571